Global heparin market to be valued at $15b by 2030

One key driver is the innovation in drug delivery systems and formulations.

The global heparin market is expected to reach $15b by 2030 amidst the rising incidence of cardiovascular diseases and an ageing population, said DelveInsight.

One key driver for the sector’s growth is the innovation in drug delivery systems and formulations, including low molecular weight heparin (LMWH) developments to improve treatment efficacy and safety.

“Additionally, the development of more efficient manufacturing processes, such as recombinant heparins, has helped meet the growing demand and reduce dependency on animal sources,” the report said.

Meanwhile, strict production regulations are expected to impact market dynamics by increasing costs and creating barriers to entry for new manufacturers.

Economic pressures and healthcare cost-control measures may limit the sector’s growth, whilst competition from alternative anticoagulants and biosimilars is expected to impact the market by providing additional treatment options.